Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | €721.30 | €766.92 | 6.324% |
Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
Biogen Inc. | 46 | 1 | 6 | 1 | €205.00 | €294.01 | 43.420% |
Vertex Pharmaceuticals Inc. | 43 | 2 | 7 | 0 | €395.00 | €386.76 | -2.086% |
Alnylam Pharmace. | 36 | 0 | 4 | 0 | €143.85 | €236.30 | 64.267% |
Intuitive Surgical Inc | 34 | 0 | 3 | 0 | €356.15 | €382.30 | 7.344% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 6 | 1 | €888.00 | €957.22 | 7.795% |
UnitedHealth Group Inc. | 33 | 1 | 5 | 0 | €468.20 | €543.72 | 16.130% |
Johnson & Johnson | 32 | 1 | 3 | 0 | €138.76 | €196.74 | 41.781% |
Tenet Healthcare | 28 | 0 | 7 | 0 | €116.00 | €121.69 | 4.908% |
Pfizer Inc. | 31 | 4 | 3 | 1 | €26.27 | €41.10 | 56.464% |
Neurocrine Bioscience | 27 | 0 | 7 | 0 | €129.05 | €140.34 | 8.749% |
Merck & Co. Inc. | 28 | 1 | 2 | 0 | €120.80 | €124.93 | 3.418% |
Thermo Fisher Scientific Inc. | 26 | 0 | 5 | 0 | €533.90 | €566.65 | 6.133% |
Edwards Lifesciences Corp. | 26 | 1 | 4 | 0 | €79.08 | €87.81 | 11.035% |
Amgen Inc. | 24 | 0 | 5 | 0 | €283.35 | €296.16 | 4.519% |
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €63.00 | €79.55 | 26.277% |
Cytokinetics Inc. | 25 | 1 | 2 | 0 | €60.50 | €85.64 | 41.559% |
Humana Inc. | 23 | 0 | 4 | 0 | €299.60 | €439.88 | 46.821% |
Stryker Corp. | 23 | 0 | 8 | 0 | €306.20 | €335.03 | 9.415% |
Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €103.20 | €184.92 | 79.186% |
Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
HCA Holdings Inc. | 22 | 0 | 6 | 0 | €287.20 | €295.60 | 2.923% |
Zoetis Inc. A | 22 | 1 | 4 | 0 | €152.58 | €198.11 | 29.841% |
AbbVie Inc. | 21 | 0 | 4 | 0 | €149.22 | €174.43 | 16.897% |